BMC Cancer 2009, 9:251 http://www.biomedcentral.com/1471-2407/9/251 21. Iacobelli S, Arno , D'Orazio A, Coletti G: Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 1986, 46:3005-10. 22. Linsley PS, Horn D, Marquardt H, Brown JP, Hellstrom I, Hellstrom KE, Ochs V, Tolentino E: Identification of a novel serum protein secreted by lung carcinoma cells. Biochem 1986, 25:2978-86. 23. Koths K, Taylor E, Halenbeck R, Casipit C, Wang A: Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scav- enger receptor cysteine-rich domain. J Biol Chem 1993, 268:14245-49. 24. Jallal B, Powell J, Zachwieja J, Brakebusch C, Germain L, Jacobs J, Iaco- belli S, Ullrich A: Suppression of tumor growth in vivo by local and systemic 90 K level increase. Cancer Res 1995, 55:3223-27. 25. Iacobelli S, Bucci I, D'Egidio M, Guiliani C, Natoli C, Tinari N, Rubin- stein M, Schlessinger J: Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS 1993, 319:59-65. 26. Natoli C, Garufi C, Tinari N, D'Egidio M, Lesti G, Gaspari LA, Visini R, Iacobelli S: Dynamic test with recombinant interferon- alpha-2b: effect on 90 K and other tumour-associated anti- gens in cancer patients without evidence of disease. Br J Can- cer 1993, 67:564-67. 27. Iacobelli S, Sismondi M, Giai M, D'Egidio N, Tinari C, Amatetti P, Di Stefano P, Natoli C: Prognostic value of a novel circulating serum 90 K antigen in breast cancer. Br J Cancer 1994, 69:172-176. 28. Greco C, Vona R, Cosimelli M, Matarrese P, Straface E, Scordati P, Giannarelli D, Casale V, Assisi D, Mottolese M, Moles A, Malorni W: Cell surface overexpression of galectin-3 and the presence of its ligand 90 K in the blood plasma as determinants in colon neoplastic lesions. Glycobiology 2004, 14:783-92. 29. Iacobelli S, Ullrich A, Tinari N, Ortona L, Tamburrini E, D'Egidio M, Ghinelli F, Sighinolfi L, Piazza M, Chirianni A, Guerra L, Natoli C: The 90 K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. J of Acq Imm Defic Syn and Hum Retrovir 1995, 10:450-56. 30. Natoli C, lacobelli S, Ghinelli F: Unusually high level of a tumor associated antigen in the serum of human immunodeficiency virus seropositive individuals. J Infect Dis 1991, 164:616-17. 31. Resnick D, Pearson A, Krieger M: The SRCR superfamily: a fam- ily reminiscent of the Ig superfamily. Trends Biochem Sci 1994, 19:5-8. 32. Künzli BM, Berberat PO, Zhu ZW, Martignoni M, Kleef J, Tempia- Caliera A, Fukuda M, Zimmermann A, Friess H, Buchler MW: Influ- ences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer 2002, 94:228-39. 33. Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, Mucilli F, Ullrich A, Iacobelli S: Expression of 90 K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res 2002, 62:2535-9. 34. Ozaki Y, Kontani K, Hanaoka J, Chano T, Teramoto K, Tezuka N, Sawai S, Fujino S, Yoshiki T, Okabe H, Ohkubo I: Expression and immunogenicity of a tumor-associated antigen, 90 K/Mac-2 binding protein, in lung carcinoma. Cancer 2002, 95:1954-62. 35. Park YP, Choi SC, Kim JH, Song EY, Kim JW, Yoon DY, Yeom YI, Lim JS, Kim JW, Park SG, Lee HG: Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int J Cancer 2007, 120:813-20. 36. Ulmer T, Keeler V, Loh L, Chibbar R, Torlakovic E, André S, Gabius HJ, Laferté S: Tumor-associated antigen 90 K/Mac-2 binding protein: possible role in colon cancer. J Cellular Biochem 2006, 98:1351-66. 37. Sasaki T, Brakebusch C, Engel J, Timpl R: Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self- assembles into ring-like structures and binds beta1- integrins, collagens and fibronectin. EMBO J 1998, 17:1606-13. 38. Muller SA, Sasaki T, Bork P, Wolpensinger B, Schulthess T, Timpl R, Engel A, Engel J: Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structures. J Mol Biol 1999, 291:801-13. 39. Bair E, Nagle R, Ulmer TA, Laferté S, Bowden TG: 90 K/Mac-2 bind- ing protein is expressed in prostate cancer and induces pro- matrilysin espression. Prostate 2005, 66:283-293. 40. Zucker S, Vacirca J: Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-17. 41. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein M, Natoli C, Shawver L, Schlessinger J, Iacobelli S: The secreted tumor-associated antigen 90 K is a potent immune stimulator. J Biol Chem 1994, 269:18401-7. 42. Powell TJ, Schreck R, McCall M, Hui R, Rice A, App H, Azam M, Ull- rich A, Shawver LK: A tumor-derived protein which provides T- cell costimulation through accessory cell activation. J Immu- notherapy 1995, 17:209-221. 43. Fornarini B, Iacobelli S, Tinari N, Natoli C, De Martino M, Sabatino G: Human milk 90 K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol 1999, 115:91-4. 44. D'Ostilio N, Sabatino G, Natoli C, Ullrich A, Iacobelli S: 90 K (Mac- 2 BP) in human milk. Clin Exp Immunol 1996, 104:543-46. 45. Friedman J, Trahey M, Weissman I: Cloning and characterization of cyclophilin C-associated protein: a candidate natural cel- lular ligand for cyclophilin C. Proc Natl Acad Sci USA 1993, 90:6815-19. 46. Chicheportiche Y, Vassalli P: Cloning and expression of a mouse macrophage cDNA coding for a membrane glycoprotein of the scavenger receptor cysteine-rich domain family. J Biol Chem 1994, 269:5512-17. 47. Trahey M, Weissman IL: Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endo- toxin and proinflammatory responses in vivo. Proc Natl Acad Sci USA 1999, 96:3006-11. 48. Barthold SW, Coleman GL, Bhatt PN, Osbaldiston GW, Jonas AM: The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci 1976, 26:889-94. 49. Fiala ES: Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 1977, 40(5 Suppl):2436-45. 50. Laferté S, Prokopishyn NL, Moyana T, Bird RP: Monoclonal anti- body recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane-induced rat colon tumors and human colon cancer cell lines. J Cellular Biochem 1995, 57:101-119. 51. Bird RP, Good CK: The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000, 112–113:395-402. 52. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, Snover DC: Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008, 32(1):21-9. 53. Bassarova AV, Torlakovic E, Sedloev T, Hristova SL, Trifonov DV, Nesland JM: Simultaneous bilateral breast carcinoma: His- topathological characteristics and CD44/catenin-cadherin profile. Histol Histopathol 2005, 20:791-9. 54. Willis RA: Pathology of Tumours. Butterworth, London, UK; 1960:122-126. 55. Pitot HC, Dragan YP: Facts and theories concerning the mech- anisms of carcinogenesis. FASEB J 1991, 5:2280-86. 56. Lipkin M: Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 1974, 34(Suppl):878-88. 57. Farber E: The multistep nature of cancer development. Cancer Res 1984, 44:4217-23. 58. Bleiberg H, Buyse M, Galan P: Cell kinetic indicators of premalig- nant stages of colorectal cancer. Cancer 1985, 56:124-29. 59. Lieberman DA, Prindiville S, Weiss DG, Willett W, VA Cooperative Study Group 380: Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003, 290:2959-67. 60. Bleiberg H, Galand P: In vitro autoradiographic determination of cell kinetic parameters in adenocarcinomas and adjacent healthy mucosa of the human colon and rectum. Cancer Res 1976, 36:325-8. 61. Deschner EE, Lipkin M: Study of human rectal epithelial cells in vitro. III. RNA, protein, and DNA synthesis in polyps and adjacent mucosa. J Natl Cancer Inst 1970, 44:175-85. Page 10 of 11 (page number not for citation purposes)